drugset / Trial / NCT04831684
Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes
Phase 1/2
Completed
79 enrolled
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabNational Institutes of Health (NIH) · collab
RandomizedParallel-groupQuadruple-blindBasic science
Summary
This study evaluates the effects of the medication GET73 among non-treatment-seeking individuals who regularly drink alcohol. Participants in the study will take GET73 or placebo for an 8-day study. There are 4 study visits including 2 MRI scans.
Timeline
- Start
- 2021-09-15
- Primary completion
- 2025-12-29
- Completion
- 2025-12-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GET73 | Small molecule | — | — |